-

Global Transdermal Scopolamine Market to Reach $528.5 Million by 2027 at a 5.3% CAGR - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Transdermal Scopolamine: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Global Transdermal Scopolamine Market to Reach $528.5 Million by 2027

In the changed post COVID-19 business landscape, the global market for Transdermal Scopolamine estimated at US$368.7 Million in the year 2020, is projected to reach a revised size of US$528.5 Million by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027.

The U.S. Market is Estimated at $108.7 Million, While China is Forecast to Grow at 4.9% CAGR

The Transdermal Scopolamine market in the U.S. is estimated at US$108.7 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$93.2 Million by the year 2027 trailing a CAGR of 4.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5% and 4.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Select Competitors (Total 41 Featured) -

  • Alchem International
  • Alkaloids of Australia
  • ALZA Corporation
  • Baxter International Inc.
  • Caleb Pharmaceuticals Inc
  • Centroflora-Cms
  • Fine Chemicals Corporation
  • GlaxoSmithKline Plc
  • Myungmoon Pharma Co. Ltd.
  • Novartis AG
  • Perrigo Co. Plc
  • Phytex Australia

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Transdermal Scopolamine - Global Key Competitors Percentage Market Share in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

Companies Mentioned

  • Alchem International
  • Alkaloids of Australia
  • ALZA Corporation
  • Baxter International Inc.
  • Caleb Pharmaceuticals Inc
  • Centroflora-Cms
  • Fine Chemicals Corporation
  • GlaxoSmithKline Plc
  • Myungmoon Pharma Co. Ltd.
  • Novartis AG
  • Perrigo Co. Plc
  • Phytex Australia

For more information about this report visit https://www.researchandmarkets.com/r/mjl3iv

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Industry:

Research and Markets

Release Versions
English

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Process Analytical Technology Market and Competition Forecast 2025-2032 Featuring ABB, Emerson Electric Co., Endress+Hauser, Thermo Fisher Scientific, Agilent Technologies, Schneider Electric and More - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Process Analytical Technology Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. Process analytical technology is redefining quality assurance for manufacturing leaders across life sciences, industrial, and food sectors, driving next-generation process efficiency and real-time compliance. Senior decision-makers evaluating innovation strategies will find this report essential for aligning technology investments to evolvin...

Growth & Investment Opportunities in the Booming Quantum AI Market: Total Revenues to Reach $7.79 Billion by 2035 at an Astonishing 35.29% CAGR - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Quantum AI Market, Till 2035: Distribution by Type of Component, Type of Deployment, Type of Application, End-User, Type of Enterprise and Geographical Regions: Industry Trends and Global Forecasts" has been added to ResearchAndMarkets.com's offering. The global quantum AI market is set to expand remarkably from USD 280 million in 2023 to USD 7.79 billion by 2035, with a CAGR of 35.29%. This market evolution underscores the synergy between quantum computing and AI,...

AI Transformation in China's E-Commerce Ecosystem: Regulation, Infrastructure, and Digital Payments Integration 2025-2030 - Heavy Investment and Digital Infrastructure Fuel China's Global Leadership - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "AI Transformation in China's E-Commerce Ecosystem: Regulation, Infrastructure, and Digital Payments Integration 2025" has been added to ResearchAndMarkets.com's offering. This report delivers comprehensive insights into how Artificial Intelligence (AI), particularly Generative AI, is transforming China's E-Commerce, fintech, and payments landscape through large-scale platform integration, regulatory innovation, and digital infrastructure expansion. China expands en...
Back to Newsroom